Cargando…
Insulin-like growth factor binding protein-2 alters the sensitivity of breast cancer cells to chemotherapy
Autores principales: | Foulstone, EJ, Holly, JM, Zeng, L, Winters, ZE, Perks, CM |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875584/ http://dx.doi.org/10.1186/bcr2519 |
Ejemplares similares
-
Insulin-like growth factor binding protein 3 modulates epidermal growth factor (EGF)-induced growth of breast epithelial cells by altering EGF receptor internalization
por: Dennison, GJ, et al.
Publicado: (2008) -
Actions of IGF-I are differentially regulated by fatty acids in normal and breast cancer epithelial cells
por: Perks, CM, et al.
Publicado: (2008) -
Serum insulin-like growth factor binding protein 1 and C-peptide to assess insulin resistance in septic patients
por: Chelazzi, C, et al.
Publicado: (2008) -
Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor–binding protein 3?
por: Zielinska, Hanna A, et al.
Publicado: (2015) -
Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome
por: Vestey, Sarah B, et al.
Publicado: (2005)